Results
1 -
10 of
16Fairhurst Robin A., Knoepfel Thomas, Leblanc Catherine, Buschmann Nicole, Gaul Christoph, Blank Jutta, Galuba Inga, Trappe Jörg, Zou Chao, Voshol Johannes, Genick Christine, Brunet-Lefeuvre Peggy, Bitsch Francis, Graus-Porta Diana, Furet Pascal.
Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region, Med. Chem. Commun., 2017 Advanced Neuroblastoma: Role of ALK Mutations, Neuroblastoma Targeting EGFR mutants with non-cognate kinase inhibitors in non-small cell lung cancer, Medicinal Chemistry Research Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs, Cellular and Molecular Life Sciences ALK-Mutated Non-Small-Cell Lung Cancer: A New Strategy for Cancer Treatment, Lung Targeting ALK in pediatric RMS does not induce antitumor activity in vivo, Cancer Chemotherapy and Pharmacology Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma, Journal of Cancer Research and Clinical Oncology Development of treatment strategies for advanced neuroblastoma, International Journal of Clinical Oncology Activated ALK signals through the ERKu2013ETV5u2013RET pathway to drive neuroblastoma oncogenesis, Oncogene